AstraZeneca Medical Affairs, International Region, Luton, UK.
AstraZeneca Medical Affairs, International Region, Madrid, Spain.
Pharmaceut Med. 2021 Jan;35(1):21-29. doi: 10.1007/s40290-020-00378-1. Epub 2021 Jan 19.
The evolution of healthcare, together with the changing behaviour of healthcare professionals, means that medical affairs functions of pharmaceutical organisations are constantly reinventing themselves. The emergence of digital ways of working, expedited by the COVID-19 pandemic, means that pharmaceutical-healthcare relationships are evolving to operate in an increasingly virtual world. The value of the pharmaceutical medical affairs function is dependent on understanding customers' needs and providing the right knowledge at the right time to physicians. This requires a human-centric artificial intelligence (AI) approach for medical affairs, which allows the function to query internal and external data sets in a conversational format and receive timely, accurate and concise intelligence on their customers.
医疗保健的发展,加上医疗保健专业人员行为的变化,意味着制药企业的医学事务职能正在不断创新。数字化工作方式的出现,由于 COVID-19 大流行而加速,意味着制药与医疗保健的关系正在发展,以在日益虚拟的世界中运作。医药事务职能的价值取决于了解客户的需求,并在适当的时间向医生提供正确的知识。这需要一种以人为中心的人工智能 (AI) 方法来处理医学事务,该方法允许该职能以对话的格式查询内部和外部数据集,并及时、准确和简明地获取关于其客户的情报。